PRIVISCLBSEPrivi Speciality Chemicals LtdHighNeutral
Announced Mon, 11 May · 14:13 IST

Board approves Dividend

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.2%1-day move
₹3498.20
prior close
₹3467.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5-1.1+0.6+1.6-8.2-9.5-11.9-12.0-11.5-8.2-6.5-7.2+4.1
Up moveDown movePending
AI summary

Privi Speciality Chemicals Board approved FY2026 audited results showing strong performance. Standalone revenue grew 20.5% to Rs. 2,45,553 lakhs while PAT surged 88.7% to Rs. 47,899 lakhs. Consolidated revenue increased 22% to Rs. 2,56,369 lakhs with PAT jumping 351% to Rs. 67,574 lakhs. The Board recommended a final dividend of Rs. 10 per share (100% on Rs. 10 face value), aggregating Rs. 3,906.27 lakhs, subject to shareholder approval at the 41st AGM on August 7, 2026. Statutory auditors BSR & Co. LLP issued an unmodified opinion on both standalone and consolidated results. The company also re-appointed its Executive Director and auditors.

Likely market impact

Strong financial results with double-digit revenue growth and exceptional PAT growth signal healthy operations. The 100% dividend payout demonstrates confidence in cash generation and benefits shareholders. The stock may see positive reaction given the beat in profitability metrics.